drugset / Trial / NCT01246583

CP-690-550 Ointment For Chronic Plaque Psoriasis

NCT01246583

Phase 2 Completed 71 enrolled Pfizer
RandomizedParallel-groupDouble-blindTreatment

Summary

The study is being conducted to see whether CP-690,550 ointment has potential as a safe and effective treatment for adult patients with mild to moderate chronic plaque psoriasis.

Timeline

Start
2011-02-16
Primary completion
2011-11-29
Completion
2011-11-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Tofacitinib Small molecule 2 % Topical

Indications